spacer
spacer

PDBsum entry 4oqc

Go to PDB code: 
protein ligands metals links
Oxygen binding PDB id
4oqc

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
296 a.a.
Ligands
AZI ×2
Metals
_NA
Waters ×242
PDB id:
4oqc
Name: Oxygen binding
Title: Urate oxidase co-crystallized with azide
Structure: Uricase. Chain: a. Fragment: unp residues 2-302. Synonym: urate oxidase. Engineered: yes
Source: Aspergillus flavus. Organism_taxid: 5059. Gene: uaz, uox. Expressed in: saccharomyces cerevisiae. Expression_system_taxid: 4932
Resolution:
1.30Å     R-factor:   0.188    
Authors: N.Colloc'H,T.Prange
Key ref: L.Gabison et al. (2014). Azide inhibition of urate oxidase. Acta Crystallogr F Struct Biol Commun, 70, 896-902. PubMed id: 25005084 DOI: 10.1107/S2053230X14011753
Date:
08-Feb-14     Release date:   24-Dec-14    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q00511  (URIC_ASPFL) -  Uricase from Aspergillus flavus
Seq:
Struc:
302 a.a.
295 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.1.7.3.3  - factor independent urate hydroxylase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

      Pathway:
AMP Catabolism
      Reaction: urate + O2 + H2O = 5-hydroxyisourate + H2O2
urate
+ O2
+ H2O
= 5-hydroxyisourate
+ H2O2
      Cofactor: Copper
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1107/S2053230X14011753 Acta Crystallogr F Struct Biol Commun 70:896-902 (2014)
PubMed id: 25005084  
 
 
Azide inhibition of urate oxidase.
L.Gabison, N.Colloc'h, T.Prangé.
 
  ABSTRACT  
 
The inhibition of urate oxidase (UOX) by azide was investigated by X-ray diffraction techniques and compared with cyanide inhibition. Two well characterized sites for reagents are present in the enzyme: the dioxygen site and the substrate-binding site. To examine the selectivity of these sites towards azide inhibition, several crystallization conditions were developed. UOX was co-crystallized with azide (N3) in the presence or absence of either uric acid (UA, the natural substrate) or 8-azaxanthine (8AZA, a competitive inhibitor). In a second set of experiments, previously grown orthorhombic crystals of the UOX-UA or UOX-8AZA complexes were soaked in sodium azide solutions. In a third set of experiments, orthorhombic crystals of UOX with the exchangeable ligand 8-nitroxanthine (8NXN) were soaked in a solution containing uric acid and azide simultaneously (competitive soaking). In all assays, the soaking periods were either short (a few hours) or long (one or two months). These different experimental conditions showed that one or other of the sites, or the two sites together, could be inhibited. This also demonstrated that azide not only competes with dioxygen as cyanide does but also competes with the substrate for its enzymatic site. A model in agreement with experimental data would be an azide in equilibrium between two sites, kinetically in favour of the dioxygen site and thermodynamically in favour of the substrate-binding site.
 

 

spacer

spacer